Academic literature on the topic 'Álvaro Emidio dos'

El arqueólogo Sauza Durán hace una reflexión acerca del enigma del numen en el poemario Nômen de Emilio Álvarez y, además, analiza cómo el verbo ayuda a la construcción tanto de la literatura como de la realidad.

El libro se centra en el análisis de textos fantásticos escritos en español y catalán desde finales del siglo xix hasta el xxi. A este estudio, el autor añade aspectos ideológicos para ampliar la posibilidad de lectura de lo fantástico en los cuentos de autores españoles y catalanes de renombre, como Emilia Pardo Bazán, Miguel de Unamuno, Miguel Sawa, Pío Baroja, Luis Valera, Noel Clarasó, Álvaro Cunqueiro, Juan José Millás, José María Merino, Cristina Fernández Cubas y José María García Hernández —todos ellos en lengua castellana...

H-1 MULTIMORBILIDAD Y HEMOSIDEROSIS (ATENCIO DIANA, PARRA DIANA, HERNÁNDEZ ODISMAR) H-2 ANEMIA APLASICA SEVERA ACOMPAÑADO DE CLONAS DE HEMOGLOBINURIA PAROXISTICA NOCTURNA (MOSCOSO EVELYN, CUERVO JESSICA, PALOMINO LEONARDO, OMAÑA PAOLA, PATIÑO BONELL, GONZÁLEZ JAVIER) H-3 PURPURA TROMBOCITOPENIA TROMBÓTICA MANEJADA CON PLASMAFÉRESIS. UNA ENTIDAD DE NUNCA OLVIDAR (HIGUERA JUAN, SOSSA CLAUDIA, OROZCO CARLOS, PRADA MAYRA) H-4 LINFANGIOMATOSIS ESPLÉNICA EN UN PACIENTE ADULTO (BOLAÑOS FERNANDO, BENAVIDES-LÓPEZ ERNESTO FEDERICO, MONDRAGÓN-CARDONA ÁLVARO EDUARDO, JIMÉNEZ-CANIZALES CARLOS EDUARDO) H-5 LEUCEMIA CUTIS PAPULONODULAR EN PACIENTE ADOLESCENTE, A PROPÓSITO DE UN CASO. (MONDRAGÓN-CARDONA ÁLVARO EDUARDO, DÍAZ ÁLVARO ERNESTO, BOLAÑOS FERNANDO, TURIZO HERNÁNDEZ JESÚS FRANCISCO, HERRERA-CÉSPEDES CRISTIAN EMILIO, JIMÉNEZCANIZALES CARLOS EDUARDO) H-6 PRIMER CASO DE HEMOFILIA B ADQUIRIDA EN PACIENTE CON INFECCIÓN POR VIH (PÁRAMO LAURA, AMAYA ALEJANDRA, ENCISO LEONARDO) H-7 ANEMIA MEGALOBLÁSTICA CON NIVELES DE VITAMINA B12 NORMALES, DIAGNÓSTICO DIFERENCIAL (GUTIÉRREZ MARGARITA, AMAYA ALEJANDRA, GUTIÉRREZ CAROL, BARRAGÁN ANDRÉS, ENCISO LEONARDO) H-8 HIPOTERMIA Y LINFOMA HODGKIN (OSORIO LAURA MARCELA, TAMAYO LEIDY JOHANA, ARRUBLA MATEO, ARBOLEDA NATALIA ANDREA) H-9 SARCOIDOSIS CON COMPROMISO DE MEDULA OSEA. EL ROL DEL INTERNISTA (OSWALDO E. AGUILAR, DILAN BERRIO VALENCIA, RAUL A. VALLEJO) H-10 REACCIÓN LEUCEMOIDE: PUNTOS CLAVES PARA DIFERENCIAR CON LEUCEMIA MIELOIDE CRÓNICA (VILLANUEVA JAIME, UTRIA HADER, BARROS RICARDO, ANDRADE EMY, PALACIO HUGO) H-11 POLINEUROPATÍA COMO DEBUT DE UNA AMILOIDOSIS PRIMARIA Y MIELOMA MÚLTIPLE OLIGOSECRETOR LAMBDA CON COMPROMISO SISTÉMICO (NAVARRETE LINDA, MÉNDEZ ALEJANDRO, OMAÑA PAOLA, SOLÓRZANO CARLOS, SARMIENTO EDGAR, LEGRO GIOVANNI) H-12 OCLUSIÓN DE VENA CENTRAL DE LA RETINA COMO MANIFESTACION DE LA PURPURA TROMBOCITOPENICA TROMBOTICA. REPORTE DE UN CASO (GÓMEZ YOSBANA, CASTRO ALBERTO, HERNÁNDEZ ÁNGEL, CAMARGO TOMAS) H-13 HEMATOMA EPIDURAL ESPINAL ESPONTANEO POR SOBREANTICOGULACIÓN CON CUMARINICO (BARRAGÁN ANDRÉS, CUFIÑO DIANA, MARTÍN DANIEL, GARZÓN DIANA) H-14 LINFOMA INTRAVASCULAR: UN RETO DIAGNÓSTICO (DELGADILLO VIVIAN PAOLA, MEJIA CARLOS ANDRÉS, MARÍN JUAN CAMILO, CERQUERA CATALINA) H-15 HEMOFILIA ADQUIRIDA: UN DIAGNOSTICO A CONSIDERAR (AMADO GARZÓN SANDRA, ACEVEDO RAMOS ALFREDO, MEJÍA GÓMEZ CARLOS ANDRÉS) H-16 SÍNDROME HEMOLÍTICO URÉMICO ATÍPICO POSTPARTO (CRIOLLO-VARON KEVIN, GUARIN GLORIA, SUÁREZ WILSON, ECHEVERRI JORGE, LARRARTE CAROLINA) H-17 ANEMIA POR DÉFICIT DE VITAMINA B12 CON NIVELES SÉRICOS NORMALES (RÍOS CESAR AUGUSTO, CASANOVA MARÍA EUGENIA, BALCÁZAR CARLOS, CASTELLANOS DANIEL, CELIS KAREN, CALVACHE SOFÍA, CASTRO VALERIA, CASTRO SANTIAGO) H-18 SÍNDROME DE POEMS (ESTUPIÑÁN MARÍA CAMILA, ARAGÓN DIANA MARCELA, SILVA MARCOS) H-19 SERIE DE CASOS DE 3 PACIENTES: PORFIRIA Y SU CURSO CLÍNICO (MILLÁN SONIA, LEGRO GIOVANNI, NAVARRETE LINDA)

C-1. DISMINUCIÓN DE LA MORBIMORTALIDAD EN FALLA CARDIACA, MEJORÍA DE LA FRACCIÓN DE EYECCIÓN Y CLASE FUNCIONAL CON EL USO DE SACUBUTRILO / VALSARTAN (PEÑA QUINTERO HAROLD, KOGA CORREA JENNY CAROLINE, TASCON GUEVARA BRIGITTE NATHALIA C-2. CORAZÓN CARCINOIDE Y TUMOR NEUROENDOCRINO METASTÁSICO (AGUDELO CARLOS, TRUJILLO DANILO, LUNA FREDY, ORTIZ CARLOS, GUERRA JOAQUÍN.) C-3. DEXTROCARDIA ADQUIRIDA (AVILA NATALIA, CELEMIN CARLOS, VARGAS JUAN GUILLERMO) C-4. ENDOCARDITIS INFECCIOSA EN VÁLVULA PROTÉSICA AORTICA POR STREPTOCOCCUS GORDONII (NAVARRETE LINDA, FUENTES CARLOS, ÁLVAREZ CAMILO, RESTREPO CARLOS, SUPELANO MARIO, MORA JAVIER) C-5. COMPROMISO CARDÍACO EN AMILOIDOSIS (BETANCUR SALAZAR KELLY JOHANNA, RONDÓN CARVAJAL JULIÁN FELIPE, THORRENS RÍOS JOSE GREGORIO) C-6. INSUFICIENCIA TRICUSPIDEA PRIMARIA ASOCIADA A INSUFICIENCIA CARDIACA DERECHA, LA VÁLVULA OLVIDADA (MENDOZA FERNÁN, ROMERO JOSÉ, LONDOÑO GABRIEL, IDROVO CAROLINA, MENDOZA LAURA VICTORIA, NÚÑEZ FEDERICO, CAICEDO VÍCTOR) C-7. COMUNICACIÓN INTERVENTRICULAR COMO COMPLICACIÓN TEMPRANA POST INFARTO DE CARA ANTERIOR (MENDOZA FERNÁN, LONDOÑO GABRIEL, CASTAÑO ANGIE MARCELA, MENDOZA LAURA VICTORIA, ANDRADE DARÍO, FEDERICO NÚÑEZ, CAICEDO VÍCTOR C-8. COMPLICACIONES CARDIOVASCULARES DEL CONSUMO DE COCAÍNA (SANTAMARIA ALZA YEISON, HERNANDEZ CELIS ANNIE) C-9. PERFIL CLÍNICO Y DEMOGRÁFICO DE PACIENTES CON FALLA CARDIACA AGUDA. ANÁLISIS DESCRIPTIVO DE COHORTE. (JUAN EMILIO, AMAYA NICOLAS, JUAN MARIETTA, ARBELAEZ LINA, CALVO LAUREN, VALENCIA MARGARITA, MARIÑO ALEJANDRO, GARCIA-PEÑA ANGEL) C-10. ABSCESO AÓRTICO PERIPROTÉSICO ROTO (CACERES EDWARD, JUAN MARIETTA, OSPINA DIEGO, MOLINA GERMAN, RIOS GIOVANNY, GARCIA-PEÑA ANGEL) C-11. MIOCARDITIS Y PUENTE MUSCULAR: ASOCIACIÓN CON MANIFESTACIONES SEMEJANTES AL SINDROME CORONARIO (MENDOZA FERNÁN, MORALES MILENA) C-12. INSUFICIENCIA CARDIACA AVANZADA, DIABETES Y CIRROSIS COMO MANIFESTACIONES DE UN CASO DE HEMOCROMATOSIS HEREDITARIA (MENDOZA FERNÁN, ORTIZ PAOLA, MEDINA OSCAR, JARAMILLO CLAUDIA, ARIZA GERARDO) C-13. RELACIÓN ENTRE EL RESULTADO DE TROPONINA CARDÍACA Y LA MORTALIDAD EN UN HOSPITAL DE SEGUNDO NIVEL DE ATENCIÓN (ARAUJO DURAN JORGE, CONCHA DIANA, BARROS CAMILO) C-14. COMPARACIÓN DE ESCALAS DE PREDICCIÓN DE RIESGO EN DOLOR TORÁCICO, EN UN HOSPITAL DE ALTA COMPLEJIDAD (TORRALBA ADRIÁN FELIPE, NAVARRO ALBERTO, ORTIZ CARLOS) C-15. MIOCARDIOPATIA DILATADA PERIPARTO: PRESENTACION DE UN CASO (GRANELA KATYA, BROCHADO LEONARDO) C-16. PROTOCOLOS ADAPT VS HEART EN EL DIAGNÓSTICO DEL DOLOR TORÁCICO: DISEÑO DE UN ENSAYO CLÍNICO ALEATORIZADO PRAGMATICO (SPROCKEL JOHN*, DIAZTAGLE JUAN*, CHAVES WALTER, ALVAREZ JOHAN, BOHORQUEZ JUAN, HURTADO EDUARDO, HERRERA GEOBER, ALZATE JUAN, OLAYA ALEJANDRO) C-17. AGENESIA DE ARTERIA PULMONAR UNILATERAL EN ADULTO CON TETRALOGÍA DE FALLOT (CASTRO LEIDY, CÁRDENAS LAURA, SPROCKEL JOHN) C-18. PERICARDITIS CONSTRICTIVA POR TUBERCULOSIS REPORTE DE CASO CLINICO (GONZÁLEZ YESENIA, ARTETA SHEILA) C-19. UTILIDAD DIAGNOSTICA DEL SIGNO DE FRANK EN PACIENTES CON ENFERMDEDAD CARDIOVASCULAR ATENDIDOS EN UN HOSPITAL DE TECER NIVEL (ÁLVAREZ LUIS, BURITICÁ WILSON, CALDERÓN LAURA, LOSADA MARÍA, MACÍAS DANIELA, VERGARA JHON) C-20. EXPERIENCIA EN CATETERISMO CARDIACO DERECHO EN PACIENTES CON SOSPECHA DE HIPERTENSION PULMONAR EN EL HOSPITAL GENERAL DE MÉXICO (JURADO YAMILE, CUETO GUILLERMO, GÓMEZ SAMUEL) C-21. COMPARACIÓN DE RESULTADOS DE ECOCARDIOGRAMA ESTRÉS Y PRUEBA DE ESFUERZO EN PACIENTES DE CONSULTA ESPECIALIZADA (YASNÓ NAVIA PAOLA ANDREA, LÓPEZ GARZÓN NELSON ADOLFO, MARIA VIRGINIA PINZÓN) C-22. ANGIOGRAFÍA CORONARIA: HALLAZGOS Y PERFIL CLÍNICO EN 100 PACIENTES EN LA UNIDAD DE HEMODINAMIA DE UN CENTRO DE REFERENCIA CARDIOVASCULAR, REPORTE PRELIMINAR (DURAN GUTIÉRREZ LUIS FERNANDO, ALVAREZ ROSERO RAFAEL ALBERTO, JIMÉNEZ CANIZALES CARLOS EDUARDO, PEÑA MURCIA ANGIE DANIELA, VARGAS RIVEROS LUIS FERNANDO, SANTOS POLANCO LUIS FERNANDO, MONDRAGÓN CARDONA ÁLVARO EDUARDO) C-23. HEMANGIOMA CARDIACO DEL NODO AURICULOVENTRICULAR (HERNÁNDEZ JENIFFER, PINTO DIEGO C-24. SÍNDROME DE KOUNIS INDUCIDO POR N-ACETIL CISTEÍNA (PIZZA RESTREPO MARIA JULIANA, ÁLVAREZ MORENO ADRIANA, OCAMPO YEPES MARIA CAMILA, CEBALLOS ZAPATA KATHERINE, THORRENS RIOS JOSE GREGORIO) C-25. CARACTERIZACIÓN DE LA POBLACIÓN CON ENDOCARDITIS INFECCIOSA EN EL HOSPITAL DEPARTAMENTAL SANTA SOFÍA DE CALDAS ENTRE EL 2012-2016 (BECERRA LUZ YANETH, GARCÍA CRISTIAN, SÁNCHEZ FABIO MAURICIO) C-26. TUMORES CARDIACOS PRIMITIVOS BENIGNOS: MIXOMA CUYA PRESENTACIÓN CLÍNICA FUE UN SÍNDROME CORONARIO AGUDO (MENDOZA FERNÁN, GUTIÉRREZ FELIPE, LONDOÑO GABRIEL, QUINTERO JUAN, ROMERO JOSÉ, VEGA IVÁN, MENDOZA LAURA, NÚÑEZ FEDERICO, ANDRADE DARÍO, CAICEDO VÍCTOR) C-27. DERRAME PERICARDICO COMO MANIFESTACIÓN DE MALARIA COMPLICADA (GÓMEZ PACHÓN CAMILO ANDRÉS, CRIOLLO VARÓN KEVIN LEANDRO, FIGUEROA CRISTIAN, TORRES DAVID, DUQUE RUBÉN, PÉREZ FRANCO JAIRO ENRIQUE.) C-28. PERICARDITIS POSTINFARTO ASOCIADO A HEMOPERICARDIO Y TAPONAMIENTO CARDIACO (RAMIREZ GARCIA MONICA, CORREA ALDANA JOHN JAIRO, PUENTES CASTRILLON MARIA ELCY, FIERRO RODRIGUEZ DORA EMILIA, DOMINGUEZ RUIZ JUAN DIEGO)

<p>Emilio Tuñón Álvarez, 1959. Arquitecto por la Escuela Técnica Superior de Arquitectura de Madrid (ETSAM), 1981; Doctor Arquitecto, 2000; Catedrático de Proyectos Arquitectónicos de la ETSAM, 2016. Medalla de Oro al Mérito en las Bellas Artes por el gobierno de España, 2014; Premio Mies van der Rohe, 2007; Premio de Arquitectura Contemporánea de la Unión Europea, 2007; Premio Nacional de Arquitectura Española, 2003; Premios FAD, 2001, 2007 y 2011.</p><p>Tal y como indica su web profesional, sus artículos y sus proyectos, ganadores en multitud de ocasiones de diversos concursos públicos de arquitectura, han sido publicados por numerosas revistas nacionales e internacionales, y su trabajo se recoge en numerosas monografías, de entre las cuales podemos destacar las publicadas por la revista AV Proyectos 65 en 2014 y la revista El Croquis 161 en 2012, Mansilla + Tuñón Architects, publicado por Edil Stampa en 2012, revista AV Monografías 144 en 2011, Mansilla + Tuñón publicado por Electa en 2007, el Croquis 115-116 (II) en 2003, revista 2G, 27 en 2003.</p>

NF-1 MANEJO MULTIDIMENSIONAL DE CALCIFILAXIS URÉMICA (PATIÑO GIRALDO SANTIAGO) NF-2 SÍNDROME PULMON RIÑON (RUBIANO WENDY, SÁENZ OSCAR) NF-3 PRESENTACIÓN ATÍPICA DE NEFROPATÍA POR IGA (MUÑOZ OSCAR, ÁVILA VANEZA, GONZALEZ IVAN) NF-4 PERITONITIS ASOCIADA A DIÁLISIS PERITONEAL POR MYCOBACTERIUM FORTUITUM (SANDOVAL JENNIFER, BERNAL EDGAR, TAPIAS ELSA, ARDILA MANUEL) NF-5 HEMOSIDEROSIS EN PACIENTES TRATADOS PARA ANEMIA FERROPENICA EN DIÁLISIS (AGUDELO CARLOS, NAVARRO ALBERTO, YUCUMÁ SAMUEL, WANCJER BENJAMÍN, MOLANO ALEJANDRA) NF-6 FALLA RENAL AGUDA POR ACTIvACIÓN DE LA vÍA ALTERNA DEL COMPLEMENTO (CASTAÑEDA CAMACHO HÉCTOR ANDRÉS, PINILLA QUINTERO LADY SAMARA, HERNÁNDEZ SIERRA ASTRID PATRICIA) NF-7 LESION RENAL AGUDA SECUNDARIA A RABDOMIOLISIS POR SALMONELLA GUARÍN GLORIA, ECHEVERRI JORGE, LARRARTE CAROLINA, SUÁREZ WILSON, FIGUEROA CHRISTIAN NF-8 CORRELACIÓN DE LAS FÓRMULAS DE LA TASA DE FILTRACIÓN GLOMERULAR ESTIMADA CON LA DEPURACIÓN DE CREATININA EN ORINA DE 24 HORAS (VARELA DIANA-CRISTINA, RESTREPO MARY-ALEJANDRA, RUIZ ALEJANDRA, GUARÍN MAYRA, TABARES MABEL, MARTÍNEZ LINA, URIBE MAURICIO) NF-9 LESIÓN RENAL AGUDA ASOCIADA A PICADURA DE AvISPAS (FIGUEROA CHRISTIAN, LARRARTE CAROLINA, SUAREZ WILSON) NF-10 SINDROME HEMOLITICO UREMICO ATIPICO Y RETIRO DE ECULIZUMAB, A PROPÓSITO DE UN CASO (ÁLVAREZ PERDOMO LUIS CARLOS, BARRAGÁN LUIS ERNESTO, HERRERA CÉSPEDES CRISTHIAN EMILIO, CUELLAR AZUERO MARÍA ISABEL, PEDRAZA ATAHUALPA PAOLA ANDREA)

The fungicide cyflufenamid (phenyl-acetamide, Fungicide Resistance Action Committee [FRAC] code U6) was approved for use in Italy in 2011 as Takumi (Certis Europe, Utrecht, The Netherlands) to control Podosphaera xanthii (Castagne) U. Braun. & N. Shishkoff, the main causal agent of cucurbit powdery mildew. Considering that strains of this pathogen have developed resistance to strobilurin (5) and demethylation inhibitor (DMI) (4) fungicides, cyflufenamid represented a viable alternative to control this disease. However, this fungicide is also prone to resistance development as illustrated by resistance of P. xanthii in Japan (3). In the 2012 and 2013 growing seasons, significant declines in cyflufenamid efficacy were observed in two experimental fields in the Apulia (AP) and Emilia-Romagna (ER) regions of Italy on Cucumis melo and Cucurbita pepo, respectively. Takumi had been applied four times at the recommended field rate of 0.15 liter/ha (15 μg/ml of active ingredient [a.i.]) each growing season since 2010 in each field. Powdery mildew-infected leaf samples were collected in 2012 from both fields (25 isolates from AP and 19 from ER), and from five gardens (one isolate per garden); while in 2013, samples were collected only from the ER field (two polyconidial isolates). Isolates were maintained on detached zucchini cotyledons (1). Sensitivity of the isolates to cyflufenamid was determined by leaf disk bioassays (4) using Takumi at 0.01, 0.1, 1, 10, 20, and 50 μg a.i./ml. The 50% effective concentration (EC50) and the minimum inhibitory concentration (MIC) values were calculated (2). Isolates collected in ER and the gardens in 2012 all had an EC50< 0.01 μg/ml, and the MIC ranged from <0.01 to <1 μg/ml. Isolates from AP in 2012 had elevated EC50 values, from 0.230 to >50 μg/ml, and MIC values from <10 to >50 μg/ml; by 2013, the EC50 values of ER isolates ranged from 3.35 to >50 μg/ml. Based on the mean EC50 value of 0.0019 μg/ml for sensitive isolates of P. xanthii in Japan (2), isolates from both the ER field and gardens in 2012 were considered sensitive to cyflufenamid. Additionally, EC50 values of AP isolates from 2012 and ER isolates from 2013 were greater than those of sensitive isolates, indicating a shift in sensitivity toward resistance to cyflufenamid (resistance factor >100 [2]). Consequently, poor control of powdery mildew with cyflufenamid applications in the AP and ER trials was most likely a result of fungicide resistance. Isolates from these fields were exposed to selection pressure for fungicide resistance because cyflufenamid was applied more times than permitted in the label instructions. However, control of powdery mildew in 2013 was not as effective as in previous years in commercial fields in AP (C. Dongiovanni, personal communication). This observation, combined with proof of reduced sensitivity of some P. xanthii strains in Italy to cyflufenamid, highlights the need for implementing resistance management strategies to minimize the risk of fungicide resistant strains developing in cucurbit fields. References: (1) B. Álvarez and J. A. Torés. Bol. San. Veg. Plagas 23:283, 1997. (2) M. Haramoto et al. J. Pest. Sci. 31:397, 2006. (3) H. Hosokawa et al. Jpn. J. Phytopathol. 72:260, 2006. (4) M. T. McGrath et al. Plant Dis. 80:697, 1996. (5) M. T. McGrath and N. Shishkoff. Plant. Dis. 87:1007, 2003.

Background:Considerable epidemiological variations in prevalence of Behçet’s disease (BD) have been reported. These disparities may either reflect geographical differences, methodological artifacts, changes over time or random fluctuations. In Spain, published BD’s epidemiological studies are scarce.Objectives:To study epidemiological and clinical domains of BD in a well-defined population of Northern Spain, as well as, to compare results with other regions.Methods:We included all consecutive 111 patients, diagnosed of definitive or possible BD by expert rheumatologists between 1980 and 2019. Two Classification criteria were applied: a) International Study Group (ISG) for BD(Lancet. 1990; 335:1078-80), and b) International Criteria for BD (ICBD)(J Eur Acad Dermatol Venereol. 2014; 28:338-47). In addition, a literature review of Medline publications was carried out.Results:In our study, prevalence was higher than in most European populations regardless of the diagnostic criteria applied. Incidence was low (expert opinion: 0.021, ICBD: 0.016, ISG: 0.012). Mean age at onset (36.8±13.2) and gender distribution (55.9% females) were similar to other countries. Pathergy test was performed in 9% of patients giving low results (25.2%). Clinical domains’ frequency was in line with other regions except vascular and gastrointestinal involvement, which were lower. (TABLE)Conclusion:BD’s prevalence in Northern Spain is higher than in most European populations. These differences likely reflect a combination of true geographic variation, methodological artifacts as well as the easy access to Public Health System and its efficiency. In contrast, clinical phenotypes are similar to other regions.TABLEDiagnostic criteria and study periodn cases / population sizeMean age at onset and sex (%females)Prevalence (over 100000) / incidenceOral / genital ulcers (%)Skin lessions/ pathergy test (%)Ocular involvement (%)Joint involvement (%)Neurobehcet/ Vascular/ Gastrointestinal involvement (%)Herrero, A et al. Southern Europe (Cantabria, Spain)Expert opinion, ISG, ICBD / 1980-2019111 (expert opinion) / 86 (ICBD) / 65 (ISG) / 58107836.8±13.2/ 55.919.1 (expert opinion), 14.8 (ICBD), 11.2 (ISG) / 0.021 (expert opinion), 0.016 (ICBD), 0.012 (ISG)99 / 53.168.4 / 25. 235.168.518 / 10 / 4.5Calamia, K. T. et al. North America (Minnesota, USA)ISG / 1960-200513 / NR31 / 305.2 / 0.38100 / 6285 / NR624623 / 23 / NRAltenburg, A. et al. Northern Europe (Berlin, Germany)ISG and ABD classification tree / 1961-2005590 / 339134426 / 584.9 / 1 (estimated)98.5 / 63.762.5 / 33.758.15310.9 / 22.7 / 11.6Mohammad, A. et al. Northern Europe (Skane County, Sweden)ISG / 1997-201040 / 80931730.5 / 334.9 / 0.2100 / 8088 / NR53400 / 20 / NRMahr, A. et al. Southern Europe (Seine-Saint-Denis County, France)ISG / 200379 / 109441227.6 / 437.1 / NR100 / 8090 / 20515910 / NR / 10Salvarani, C. et al. Southern Europe (Reggio Emilia, Italy)ISG, 1988-200518 / 48696133 / 503.7 / 0.24100 / 78100 / NR565011 / 6 / NRAzizlerli, G. et al. Middle East (Istambul, Turkey)ISG / prevalence study101 / 23986NR / 48.542 / NR100 / 70.2Not globally reported / 69.327.7Not globally reportedNR / Not globally reported / NRDavatchi, F. et al. Middle East (Iran nationwide)Expert opinion / 1975-20187641 / NR25.6 / 44.280 / NR97.5 / 64.462.2 / 50.455.638.13.9 / 8.9 / 6.8Krause, I. et al. Middle East (Galilee, Israel)ISG / 15 years (not specific years have been reported)112 / 73700030.6 / 4715.2 / NRNR / 6841 / 44.4587011.6 / Not globally reported / NRNishiyama, M. et al. Asia (Japan nationwide)1987 JCBD / 19913316 / NR35.7 / 50.6NR / NR98.2 / 73.287.1 / 43.869.156.911 / 8.9 / 15.5Disclosure of Interests:Alba Herrero Morant: None declared, Guillermo Suárez Amorín: None declared, Lara Sanchez Bilbao: None declared, Carmen Álvarez Reguera: None declared, David Martínez-López: None declared, José Luis Martín-Varillas Grant/research support from: AbbVie, Pfizer, Janssen and Celgene, Speakers bureau: Pfizer and Lilly, Patricia Setien Preciados: None declared, M. Cristina Mata Arnaiz: None declared, Rosalía Demetrio-Pablo: None declared, Miguel Ángel Gordo Vega: None declared, Miguel Á. González-Gay Grant/research support from: AbbVie, MSD and Roche, Speakers bureau: AbbVie, MSD and Roche, Ricardo Blanco Grant/research support from: Abbvie, MSD and Roche, Consultant of: Abbvie, Pfizer, Roche, Bristol-Myers, Janssen and MSD, Speakers bureau: Abbvie, Pfizer, Roche, Bristol-Myers, Janssen, Lilly and MSD

Made available in DSpace on 2016-03-15T19:48:30Z (GMT). No. of bitstreams: 1 Tiago Silveira da Silva.pdf: 582665 bytes, checksum: b73b396f56c4672b3885d3c79448038c (MD5) Previous issue date: 2014-07-31
Instituto Presbiteriano Mackenzie
This research on the historic way will reflect about the Rev. Álvaro Emidio dos Reis (1864-1925) life and acting, analyzing his profile as Presbyterian Pastor, controversialist leader and writer in the city of Rio de Janeiro, in the beginning of XX Century. Particularly, to observe the emphasis that he gave to implant new communities on the suburbs of Rio de Janeiro and other localities, using the work of lay people of his church as essential element. We sought to show in this essay the Álvaro Reis career as Pastor, his several initiative inside Brazilian Presbyterian Church and his activities along his ministry. We investigate the origins of Christian Endeavor movement and others missionary movements and para ecclesiastical, with similar goals, involving lay people in the missionary activity in second half of XIX Century. We research, in special case, the Christianity Endeavor in Rio de Janeiro Presbyterian Church, in the period of Rev. Alvaro Reis pastorate and the lay involvement of this church in the activities of urban mission in the Rio de Janeiro city, in expansion in the beginning of XX Century. Finally, we sought demonstrate the dynamic that involved the lays of Rio de Janeiro Presbyterian Church, in activities of urban mission resulted in several new churches that exist up to today
A presente pesquisa de cunho histórico refletirá a respeito da vida e atuação do Rev. Álvaro Emídio dos Reis (1864-1925), analisando seu perfil como pastor presbiteriano, líder e escritor polemista no Rio de Janeiro, no início do séc. XX. Em particular, observar a ênfase que deu à implantação de novas comunidades nos subúrbios do Rio e outras localidades, usando como elemento essencial o trabalho dos leigos de sua igreja. Procuramos mostrar neste trabalho a carreira de Álvaro Reis como pastor, suas diversas iniciativas dentro da Igreja Presbiteriana do Brasil e as atividades que exerceu ao longo de seu ministério. Investigamos as origens do movimento de Esforço Cristão e outros movimentos missionários e para-eclesiáticos, com objetivos semelhantes, envolvendo os leigos na atividade missionária na segunda metade do séc XIX. Pesquisamos, em especial, o Esforço Cristão na Igreja Presbiteriana do Rio de Janeiro, no período do pastorado do Rev. Álvaro Reis e o envolvimento do leigo dessa igreja na atividade de missões urbanas na cidade do Rio de Janeiro, em expansão no início do séc. XX. Finalmente, procuramos demonstrar que a dinâmica que envolveu os leigos da Igreja Presbiteriana do Rio, em atividades de missões urbanas resultou em diversas novas igrejas que perduram até os dias de hoje.